Inorganic Chemistry
Article
Hz). ESI-MS (C19H35F3O3P2PtS) m/z: [M − OTf], 508.19; [M −
OTf + acetone], 566.23. Anal. Calcd. for C19H35F3O3P2PtS: C, 34.70;
H, 5.36. Found: C, 34.85; H, 5.17.
(d, 2H, ArH, J = 9 Hz), 7.31−7.34 (d, 4H, PtArHα, J = 12 Hz, JArH−Pt =
24 Hz), 7.04−7.09 (t, 4H, PtArHβ, J = 15 Hz), 6.95−6.97 (t, 2H,
PtArHγ, J = 6 Hz), 6.66−6.71 (t, 1H, ArH, J = 15 Hz), 5.83 (bs, 2H,
ArNH2), 1.31−1.35 (m, 24H, PCH2), 1.07−1.17 (m, 36H, PCH3).
31P{1H} NMR (CD2Cl2, 121.4 MHz): δ 12.88 (bs; 195Pt satellites,
1JPt−P = 2696 Hz). ESI-MS (C56H83N5O6P4Pt2) m/z: [M − ONO2]+,
1373.47; [M − 2ONO2]2+, 655.74. Anal. Calcd. for C56H83N5O6P4Pt2:
C, 46.83; H, 5.82; N, 4.88. Found: C, 47.08; H, 5.79; N, 5.26.
General Procedure for Synthesis of 13−15. Into a 2 dram vial
was weighed 2,6-bis(pyrid-4-ylethynyl) aniline (1; 1 mg, 3.4 μmol)
with bromo(4-methoxy)bis(triethylphosphine)-, (SP-4-3)platinum
(10; 4.2 mg, 6.8 μmol), iodo(4-nitrophenyl)bis(triethylphosphine)-,
(SP-4-3)platinum (11; 4.6 mg, 6.8 μmol), or bromophenylbis-
(triethylphosphine) palladium (12; 3.4 mg, 6.8 μmol) in a 1:2
stoichiometric ratio. Two equivalents of AgOTf (1.7 mg, 6.8 μmol)
was then added to the vial. CH2Cl2 (1 mL) was added, and the mixture
was allowed to stir for 24 h in the dark at room temperature. The
solution was then filtered and purified by precipitation upon addition
of diethyl ether to the solution. The mixture was centrifuged, and the
supernatant was decanted. The solid was redissolved in CD2Cl2 and
characterized.
General Procedure for the Synthesis of Pt-Aryl OTf-Capped
Ligands. To a 2 dram vial was added 2,6-bis(pyrid-4-ylethynyl)
aniline (1; 1.0 mg, 3.4 μmol) or 2,6-bis(pyrid-3-ylethynyl) aniline (2;
1.0 mg, 3.4 μmol) with (1,1,1-trifluoromethanesulfonato-κO)-
phenylbis(triethylphosphine)platinum (3; 4.5 mg, 6.8 μmol) in a 1:2
stoichiometric ratio. Deuterated methylene chloride (1 mL) was then
added, and the mixture was allowed to stir for 3 h. The compound was
then purified by precipitation upon addition of diethyl ether to the
homogeneous solution. The mixture was centrifuged, and the
supernatant was decanted.
Diphenyl{μ-[4,4′-(1-amino-2,6-ethynediylbenzene)]bis-
(pyridine-κN)}tetrakis(triethylphosphine)diplatinum (4). 1H
NMR (CDCl3, 300 MHz): δ 8.56−8.60 (d, 4H, PyHα, J = 12 Hz),
7.85−7.87 (d, 4H, PyHβ, J = 3 Hz), 7.49−7.52 (d, 2H, ArH, J = 9 Hz),
7.32−7.34 (d, 4H, PtArHα, J = 6 Hz, JArH−Pt = 51 Hz), 7.05−7.09 (t,
4H, PtArHβ, J = 12 Hz), 6.95−6.97 (t, 2H, PtArHγ, J = 6 Hz), 6.69−
6.74 (t, 1H, ArH, J = 15 Hz), 5.83 (bs, 2H, ArNH2), 1.31−1.35 (m,
24H, PCH2), 1.07−1.17 (m, 36H, PCH3). 31P{1H} NMR (CD2Cl2,
1
121.4 MHz): δ 10.84 (bs; 195Pt satellites, JPt−P = 2695 Hz). ESI-MS
Platinum Methoxybenzene OTf-Capped Ligand (13). 1H
NMR (CDCl3, 300 MHz): δ 8.56−8.58 (d, 4H, PyHα, J = 6 Hz),
7.84−7.86 (d, 4H, PyHβ, J = 6 Hz), 7.49−7.51 (d, 2H, ArH, J = 6 Hz),
7.17−7.20 (d, 4H, PtArHα, J = 9 Hz, JArH−Pt = 51 Hz), 6.71−6.74 (m,
5H, PtArHβ, ArH), 5.83 (bs, 2H, ArNH2), 3.76 (s, 6H, OCH3), 1.25−
1.40 (m, 24H, PCH2), 1.06−1.16 (m, 36H, PCH3). 31P{1H} NMR
(CD2Cl2, 121.4 MHz): δ 13.39 (bs; 195Pt satellites, JPt−P = 2688 Hz).
ESI-MS (C60H87F6N3O8P4Pt2S2) m/z: [M − OTf]+, 1520.46; [M −
2OTf]2+, 685.75. Anal. Calcd. for C60H87F6N3O8P4Pt2S2 [com-
plex]·CH2Cl2·Et2O: C, 42.67; H, 5.45; N, 2.30. Found: C, 42.58; H,
5.47; N, 2.48.
(C58H83F6N3O6P4Pt2S2) m/z: [M − OTf]+, 1460.44; [M − 2OTf]2+,
655.74. Anal. Calcd. for C58H83F6N3O6P4Pt2S2: C, 43.26; H, 5.19; N,
2.61. Found: C, 43.29; H, 5.23; N, 2.55.
Diphenyl{μ-[3,3′-(1-amino-2,6-ethynediylbenzene)]bis-
(pyridine-κN)}tetrakis(triethylphosphine)diplatinum (5a). 1H
NMR (CDCl3, 300 MHz): δ 8.81 (s, 2H, PyHα), 8.56−8.58 (d, 2H,
PyHα′, J = 6 Hz), 8.30−8.32 (d, 2H, PyHγ, J = 6 Hz), 7.68−7.73 (m,
2H, PyHβ), 7.48−7.50 (d, 2H, ArH, J = 6 Hz), 7.37−7.40 (d, 4H,
PtArHβ, J = 9 Hz), 7.08 (m, 4H, PtArHα), 6.98−7.01 (m, 2H, PtArHγ),
6.69−6.75 (t, 1H, ArH, J = 18 Hz), 5.73 (bs, 2H, ArNH2), 1.34 (m,
24H, PCH2), 1.08−1.178 (m, 36H, PCH31). 31P{1H} NMR (CD2Cl2,
121.4 MHz): δ 10.84 (bs; 195Pt satellites, JPt−P = 2695 Hz). ESI-MS
(C58H83F6N3O6P4Pt2S2) m/z: [M − 2OTf]2+, 655.74. Anal. Calcd for
C58H83F6N3O6P4Pt2S2 [Complex]·CH2Cl2·Et2O: C, 42.76; H, 5.41; N,
2.37. Found: C, 42.81; H, 5.22; N, 2.51.
1
Platinum Nitrobenzene OTf-Capped Ligand (14). H NMR
(CDCl3, 300 MHz): δ 8.58−8.60 (d, 4H, PyHα, J = 6 Hz), 7.91−7.66
(m, 8H, PyHβ, Pt−ArHβ), 7.61−7.63 (d, 4H, Pt−ArHα, J = 6 Hz),
7.50−7.53 (d, 2H, ArH, J = 9 Hz), 6.69−6.75 (t, 1H, ArH, J = 18 Hz),
5.83 (bs, 2H, ArNH2), 1.28−1.39 (m, 24H, PCH2), 1.06−1.19 (m,
36H, PCH3). 31P{1H} NMR (CD2Cl2, 121.4 MHz): δ 11.98 (bs; 195Pt
satellites, JPt−P = 2597 Hz). ESI-MS (C58H81F6N5O10P4Pt2S2) m/z: [M
− OTf]+, 1550.36; [M − 2OTf]2+, 700.69. Anal. Calcd. for
C58H81F6N5O10P4Pt2S2: C, 40.97; H, 4.80; N, 4.12. Found: C, 41.14;
H, 4.92; N, 4.03.
Self-Assembly (6). In separate 2 dram vials, 1.0 mg (3.4 μmol) of
2,6-bis(pyrid-3-ylethynyl) aniline (2) and 3.4 mg (2.7 μmol) of μ-1,4-
phenylenetetrakis(triethylphosphine)bis(1,1,1-trifluoromethanesulfo-
nato-κO)diplatinum were added. Each compound was then dissolved
in 0.5 mL of deuterated methylene chloride. The μ-1,4-
phenylenetetrakis(triethylphosphine)bis(1,1,1-trifluoromethanesulfo-
nato-κO)diplatinum solution was then added dropwise to a stirring
solution of 2,6-bis(pyrid-3-ylethynyl) aniline, and the mixture was
heated to 30 °C and allowed to stir for 48 h. After this step, the
chartreuse-colored solution was filtered to remove any insoluble
kinetic byproducts (i.e., polymers). The compound was then purified
by precipitation upon addition of diethyl ether, centrifugation, and
Palladium Benzene OTf-Capped Ligand (15). 1H NMR
(CDCl3, 300 MHz): δ 8.52−8.54 (d, 4H, PyHα, J = 6 Hz), 7.85−
7.87 (d, 4H, PyHβ, J = 6 Hz), 7.48−7.50 (d, 2H, ArH, J = 6 Hz), 7.30−
7.32 (d, 4H, Pd−ArHβ, J = 6 Hz), 7.11−7.15 (t, 4H, Pd−ArHα, J = 12
Hz), 6.99−7.02 (t, 2H, Pd−ArHγ, J = 9 Hz), 6.69−6.73 (t, 1H, ArH, J
= 12 Hz), 5.78 (bs, 2H, ArNH2), 1.28−1.39 (m, 24H, PCH2), 1.06−
1.19 (m, 36H, PCH3). 31P{1H} NMR (CD2Cl2, 121.4 MHz): δ 6.78.
ESI-MS (C58H83F6N3O6P4Pd2S2) m/z: [M − 2OTf]2+, 567.68. Anal.
Calcd. for C58H83F6N3O6P4Pd2S2: C, 48.61; H, 5.84; N, 2.93. Found:
C, 48.50; H, 5.92; N, 2.95.
Steady-State Absorption and Emission Spectroscopy and
Quantum Yield Determination. Absorption and fluorescence
spectra were recorded on Hitachi U-4100 and Hitachi F-7000
spectrophotometers, respectively, with aerated spectrophotometric-
grade methylene chloride (Sigma-Aldrich) at room temperature. The
cells used in the experiments were 1-cm quartz cuvettes from Starna
Cells, Inc. All samples were freshly prepared for each measurement.
The molar absorption coefficients were determined by preparing four
samples ranging in absorption from 0.01 to 1.0 with concentrations of
0.3−95 μM. The molar absorption coeffcient for each solution was
then calculated using Beer’s law, and the four values were averaged.
Subsequent samples were then prepared to confirm the molar
absorption coefficients. Quantum yields were determined by, first,
cross-calibrating the instrument with quinine sulfate in 0.1 M H2SO4
and anthracene in ethanol. Quinine sulfate was then used to determine
the experimental quantum yields at an excitation wavelength of 365
nm with Φ = 0.55. The quantum yield measurements were performed
in multiplicates with values that were within 10% error being averaged.
1
decantation of the supernatant (>85% yield). H NMR (CDCl3, 300
MHz): δ 9.10 (s, 4H, PyHα), 8.58−8.60 (d, 4H, PyHα′, J = 6 Hz),
8.07−8.09 (d, 4H, PyHγ, J = 6 Hz), 7.63−7.68 (m, 4H, PyHβ), 7.47−
7.50 (d, 4H, ArH, J = 9 Hz), 7.21 (s, 4H, PtArH), 7.01 (s, 4H, PtArH),
6.68−6.73 (t, 2H, ArH, J = 15 Hz), 5.99 (bs, 4H, ArNH2), 1.38 (m,
48H, PCH2), 1.12−1.17 (m, 72H, PCH3). 31P{1H} NMR (CD2Cl2,
1
121.4 MHz): δ 11.29 (bs; 195Pt satellites, JPt−P = 2730 Hz). ESI-MS
(C104H154F12N6O12P8Pt4S4) m/z: [M − 2OTf]2+, 1382.39; [M −
3OTf]3+, 871.94. Anal. Calcd. for C104H154F12N6O12P8Pt4S4 [com-
plex]: C, 40.76; H, 5.06; N, 2.74. Found: C, 41.09; H, 5.27; N, 3.07.
Diphenyl{μ-[4,4′-(1-amino-2,6-ethynediylbenzene)]bis-
(pyridine-κN)}tetrakis(triethylphosphine)diplatinum (7). 2,6-
Bis(pyrid-4-ylethynyl) aniline (1; 1.0 mg, 3.4 μmol) was weighed
into a 2 dram vial. Two equivalents of each bromophenylbis-
(triethylphosphine)platinum (4.0 mg, 6.8 μmol) and AgNO3 (1.2
mg, 6.8 μmol) was also added to the same vial. CD2Cl2 (2 mL) was
then added, and the mixture was stirred at room temperature for 48 h
in the dark. The solution was then filtered twice with glass microfiber
filters to remove insoluble AgBr; a green-colored solution of 7 was
1
afforded (96% yield). H NMR (CDCl3, 300 MHz): δ 8.58−8.60 (d,
4H, PyHα, J = 6 Hz), 7.90−7.92 (d, 4H, PyHβ, J = 6 Hz), 7.48−7.51
J
dx.doi.org/10.1021/ic400491q | Inorg. Chem. XXXX, XXX, XXX−XXX